NO178260C - Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat - Google Patents

Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat

Info

Publication number: NO178260C
Authority: NO; Norway
Prior art keywords: alkyl; alkylamino; phenyl; benzyl; optionally substituted
Prior art date: 1991-03-26

Application number

NO921141A

Other languages

English (en)

Other versions

NO178260B (no

NO921141L (no

NO921141D0 (no

Inventor

Didier Festal

Denis Descours

Robert Bellemin

Jacques Decerprit

Original Assignee

Lipha

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-26

Filing date

1992-03-24

Publication date

1996-02-21

1992-03-24 Application filed by Lipha filed Critical Lipha

1992-03-24 Publication of NO921141D0 publication Critical patent/NO921141D0/no

1992-09-28 Publication of NO921141L publication Critical patent/NO921141L/no

1995-11-13 Publication of NO178260B publication Critical patent/NO178260B/no

1996-02-21 Publication of NO178260C publication Critical patent/NO178260C/no

Links

229940054051 antipsychotic indole derivative Drugs 0.000 title abstract 2
150000002475 indoles Chemical class 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 5
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000000753 cycloalkyl group Chemical group 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 2
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000004414 alkyl thio group Chemical group 0.000 abstract 1
230000000879 anti-atherosclerotic effect Effects 0.000 abstract 1
230000003178 anti-diabetic effect Effects 0.000 abstract 1
239000003472 antidiabetic agent Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
230000000055 hyoplipidemic effect Effects 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1
-1 polymethylene Polymers 0.000 abstract 1
125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Indole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO921141A 1991-03-26 1992-03-24 Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat NO178260C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9103618A FR2674522B1 (fr)	1991-03-26	1991-03-26	Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.

Publications (4)

Publication Number	Publication Date
NO921141D0 NO921141D0 (no)	1992-03-24
NO921141L NO921141L (no)	1992-09-28
NO178260B NO178260B (no)	1995-11-13
NO178260C true NO178260C (no)	1996-02-21

Family

ID=9411107

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO921141A NO178260C (no)	1991-03-26	1992-03-24	Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat

Country Status (25)

Country	Link
US (1)	US5219859A (no)
EP (1)	EP0506532B1 (no)
JP (1)	JPH0597802A (no)
KR (1)	KR950007753B1 (no)
AT (1)	ATE111078T1 (no)
AU (1)	AU658609B2 (no)
CA (1)	CA2063170A1 (no)
CS (1)	CS89592A3 (no)
DE (1)	DE69200378T2 (no)
DK (1)	DK0506532T3 (no)
ES (1)	ES2064149T3 (no)
FR (1)	FR2674522B1 (no)
HU (1)	HUT65489A (no)
IE (1)	IE65366B1 (no)
IL (1)	IL101248A (no)
MA (1)	MA22474A1 (no)
MX (1)	MX9201365A (no)
NO (1)	NO178260C (no)
NZ (1)	NZ242078A (no)
OA (1)	OA09573A (no)
RU (1)	RU2074179C1 (no)
SI (1)	SI9210305A (no)
TN (1)	TNSN92022A1 (no)
YU (1)	YU30592A (no)
ZA (1)	ZA922163B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2687402B1 (fr) *	1992-02-14	1995-06-30	Lipha	Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
WO1993024458A1 (en) *	1992-05-28	1993-12-09	Pfizer Inc.	New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)
NZ250916A (en) *	1993-02-27	1995-08-28	Nihon Nohyaku Co Ltd	N-heteroaryl-n'-phenylureas, their use as acat inhibitors
IL109568A0 (en) *	1993-05-19	1994-08-26	Fujisawa Pharmaceutical Co	Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
US5952354A (en) *	1993-07-21	1999-09-14	American Home Products Corporation	Tris carbamic acid esters: inhibitors of cholesterol absorption
DE4401893A1 (de) *	1994-01-24	1995-07-27	Bayer Ag	Substituierte Arylharnstoffe
JP3720395B2 (ja)	1994-09-20	2005-11-24	京都薬品工業株式会社	新規ヘテロ環誘導体、その製造方法およびその医薬用途
KR100241643B1 (ko) *	1995-06-06	2000-03-02	디. 제이. 우드	당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
CA2224062C (en) *	1995-06-06	2001-09-04	Pfizer Limited	Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
FI974437A7 (fi)	1995-06-06	1997-12-05	Pfizer	Substituoituja N-(indoli-2-karbonyyli)amideja ja johdannaisia glykogee nifosforylaasi-inhibiittoreina
NZ299242A (en) *	1995-09-11	1997-12-19	Nihon Nohyaku Co Ltd	N-phenyl-n'-(phenyl substituted imidazol-5-yl, -oxazol-4-yl, and -thiazol-4-yl)urea derivatives
ATE210116T1 (de)	1995-10-05	2001-12-15	Kyoto Pharma Ind	Neue heterozyklische derivate und ihre medizinische anwendung
EP0773218A1 (en) *	1995-11-13	1997-05-14	Mitsubishi Chemical Corporation	N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis
DE19616486C5 (de) *	1996-04-25	2016-06-30	Royalty Pharma Collection Trust	Verfahren zur Senkung des Blutglukosespiegels in Säugern
FR2763334A1 (fr) *	1997-05-13	1998-11-20	Lipha	Derives anthraniliques
SI1045839T1 (en) *	1997-12-16	2004-06-30	Warner-Lambert Company Llc	Novel amines as pharmaceutical agents
CN1131855C (zh) *	1997-12-16	2003-12-24	沃尼尔·朗伯公司	1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途
CA2304967C (en) *	1997-12-16	2005-06-14	Warner-Lambert Company	4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
SK282727B6 (sk)	1997-12-19	2002-11-06	Slovakofarma, A. S.	1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
US6277877B1 (en)	2000-08-15	2001-08-21	Pfizer, Inc.	Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
US7153882B2 (en)	2000-11-02	2006-12-26	The United States Of America As Represented By The Department Of Health And Human Services	Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
MXPA04010780A (es) *	2002-05-03	2005-03-07	Warner Lambert Co	Antagonistas de bombesina.
RU2318808C2 (ru) *	2002-07-17	2008-03-10	Киото Фармасьютикал Индастриз, Лтд.	Новое соединение индолина и его применение в медицине
EP1615900A1 (en) *	2003-04-01	2006-01-18	Eli Lilly And Company	Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
KR20060111898A (ko) *	2003-08-29	2006-10-30	교와 가부시키가이샤	지질-풍부-플라크의 안정화 방법 및 파열 예방방법
ATE442368T1 (de)	2005-11-30	2009-09-15	Hoffmann La Roche	3-amino-2-arylpropylazaindole und anwendungen davon
JP2009517430A (ja)	2005-11-30	2009-04-30	エフ．ホフマン−ラロシュアーゲー	３−アミノ−１−アリールプロピルインドール類及びアザ置換インドール類
RU2361581C2 (ru) *	2007-09-14	2009-07-20	Закрытое Акционерное Общество "Мастерклон"	Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
SK287385B6 (sk)	2007-11-27	2010-08-09	Hameln-Rds, A. S.	1,3-Disubstituované močoviny, spôsob ich prípravy a použitia
CN104628621A (zh) *	2015-01-22	2015-05-20	湖南华腾制药有限公司	一种氟取代吲哚衍生物的制备方法
WO2018064465A1 (en)	2016-09-29	2018-04-05	The Regents Of The University Of California	Compounds for increasing neural plasticity
RU2020102908A (ru)	2017-06-26	2021-07-27	Лунелла Байотек, Инк.	Митокетосцины: митохондриальная терапия, нацеленная на кетоновый метаболизм в раковых клетках
CN113784962B (zh)	2019-02-27	2025-04-25	加利福尼亚大学董事会	用于治疗脑部疾病的氮杂环庚三烯并-吲哚类和其他杂环
TW202333668A (zh)	2021-12-15	2023-09-01	美商德利克斯醫療公司	經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS55151505A (en) *	1979-05-14	1980-11-26	Kuraray Co Ltd	Indole agricultural and horticultural fungicide
IL85189A (en) *	1987-02-02	1992-06-21	Lilly Co Eli	Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
EP0375133A1 (en) *	1988-11-14	1990-06-27	The Upjohn Company	Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
IE903206A1 (en) *	1989-09-07	1991-03-13	Abbott Lab	Indole-, benzofuran-, and benzothiophene-containing¹lipoxygenase-inhibiting compounds
WO1991004027A1 (en) *	1989-09-15	1991-04-04	Pfizer Inc.	New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
ATE130002T1 (de) *	1990-08-13	1995-11-15	Hoechst Roussel Pharma	1-(pyridinylalkyl)-1h-indole, -indoline und analoge.
FR2680366B1 (fr) *	1991-08-13	1995-01-20	Adir	Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993005020A1 (en) *	1991-09-06	1993-03-18	Merck & Co., Inc.	Indoles as inhibitors of hiv reverse transcriptase

1991
- 1991-03-26 FR FR9103618A patent/FR2674522B1/fr not_active Expired - Fee Related
1992
- 1992-03-16 IL IL10124892A patent/IL101248A/en not_active IP Right Cessation
- 1992-03-17 CA CA002063170A patent/CA2063170A1/en not_active Abandoned
- 1992-03-20 NZ NZ242078A patent/NZ242078A/en unknown
- 1992-03-20 DE DE69200378T patent/DE69200378T2/de not_active Expired - Fee Related
- 1992-03-20 US US07/855,544 patent/US5219859A/en not_active Expired - Fee Related
- 1992-03-20 EP EP92400764A patent/EP0506532B1/fr not_active Expired - Lifetime
- 1992-03-20 ES ES92400764T patent/ES2064149T3/es not_active Expired - Lifetime
- 1992-03-20 AT AT92400764T patent/ATE111078T1/de active
- 1992-03-20 DK DK92400764.4T patent/DK0506532T3/da active
- 1992-03-20 AU AU13094/92A patent/AU658609B2/en not_active Ceased
- 1992-03-23 MA MA22763A patent/MA22474A1/fr unknown
- 1992-03-24 IE IE920937A patent/IE65366B1/en not_active IP Right Cessation
- 1992-03-24 NO NO921141A patent/NO178260C/no unknown
- 1992-03-25 CS CS92895A patent/CS89592A3/cs unknown
- 1992-03-25 ZA ZA922163A patent/ZA922163B/xx unknown
- 1992-03-25 HU HU9200997A patent/HUT65489A/hu unknown
- 1992-03-25 JP JP4067252A patent/JPH0597802A/ja active Pending
- 1992-03-25 RU SU925011235A patent/RU2074179C1/ru active
- 1992-03-26 KR KR1019920005020A patent/KR950007753B1/ko not_active Expired - Fee Related
- 1992-03-26 OA OA60177A patent/OA09573A/fr unknown
- 1992-03-26 MX MX9201365A patent/MX9201365A/es not_active IP Right Cessation
- 1992-03-26 YU YU30592A patent/YU30592A/sh unknown
- 1992-03-26 TN TNTNSN92022A patent/TNSN92022A1/fr unknown
- 1992-03-26 SI SI9210305A patent/SI9210305A/sl unknown

Also Published As

Publication number	Publication date
MA22474A1 (fr)	1992-10-01
DK0506532T3 (da)	1995-02-20
IL101248A0 (en)	1992-11-15
CA2063170A1 (en)	1992-09-27
OA09573A (fr)	1993-01-31
HUT65489A (en)	1994-06-28
DE69200378D1 (de)	1994-10-13
EP0506532A1 (fr)	1992-09-30
DE69200378T2 (de)	1995-03-09
YU30592A (sh)	1994-12-28
ES2064149T3 (es)	1995-01-16
AU658609B2 (en)	1995-04-27
CS89592A3 (en)	1992-10-14
EP0506532B1 (fr)	1994-09-07
US5219859A (en)	1993-06-15
FR2674522B1 (fr)	1993-07-16
KR920018022A (ko)	1992-10-21
MX9201365A (es)	1992-10-01
FR2674522A1 (fr)	1992-10-02
IE65366B1 (en)	1995-10-18
IE920937A1 (en)	1992-10-07
NO178260B (no)	1995-11-13
ATE111078T1 (de)	1994-09-15
NO921141L (no)	1992-09-28
NO921141D0 (no)	1992-03-24
TNSN92022A1 (fr)	1993-06-08
JPH0597802A (ja)	1993-04-20
IL101248A (en)	1996-12-05
AU1309492A (en)	1992-10-01
NZ242078A (en)	1994-10-26
SI9210305A (en)	1996-02-29
ZA922163B (en)	1993-09-27
RU2074179C1 (ru)	1997-02-27
HU9200997D0 (en)	1992-05-28
KR950007753B1 (ko)	1995-07-14

Publication	Publication Date	Title
NO178260C (no)	1996-02-21	Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat
PT96255A (pt)	1991-09-30	Processo para a preparacao de novos derivados da 1-naftil-piperazina
CY1107509T1 (el)	2013-03-13	Αμινοθειαζολες ως αναστολεις κυκλινη - εξαρτωμενων κινασεων
FI912142L (fi)	1991-11-05	Menetelmä uusien, terapeuttisesti käyttökelpoisten 5-(2-((2-aryyli-2-hydroksietyyli)amino)propyyli)-1,3-bentsodioksolijohdannaisten valmistamiseksi
NO308248B1 (no)	2000-08-21	Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
ES2132284T3 (es)	1999-08-16	Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
DK0662471T3 (da)	1998-12-21	Naphthalenderivater med affinitet over for melatonin-receptorer, fremgangsmåde til deres fremstilling og farmaceutiske samm
DK209487A (da)	1987-12-01	Silanderivater, fremgangsmaade til deres fremstilling, midler indeholdende disse forbindelser og deres anvendelse som skadedyrsbekaempelsesmidler
DK0450420T3 (da)	1995-02-20	Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
DK0916670T3 (da)	2003-09-15	Pyrrolo[3,2-b]pyridiner og deres anvendelse som 5-HT1f-agonister
NO982927L (no)	1998-06-23	Biologisk aktive benzotiazolon etanaminer
DK74185A (da)	1985-08-17	3-phenyl-2-propen-amin-derivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
DK406587A (da)	1988-02-05	1,4-dihydropyridinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
SE7908024L (sv)	1980-03-29	Heterocykliska foreningar
NO953913L (no)	1995-10-02	Perhydroisoindolderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene
DK414682A (da)	1983-03-18	N-sulfenylerede benzylsulfonamider, deres fremstilling og anvendelse som mikrobicider
DK115785D0 (da)	1985-03-13	Monosilylerede aiminophenylethylamin-derivater, fremgangsmaade til fremstilling deraf og deres anvendelse som vaekstfremmende midler
HUT42278A (en)	1987-07-28	Herbicidal compositions comprising 5-sulfamino-1-aryl-pyranol derivatives as active substance and process for preparing the active substances
ATE71367T1 (de)	1992-01-15	Verfahren zur herstellung von indolinen.
ES2194690T3 (es)	2003-12-01	Procedimiento de preparacion de oxazoles trisustituidos.
DK684888D0 (da)	1988-12-08	Nikotinoylpiperazinderivater, fremgangsmaade til deres fremstilling og deres anvendelse i terapien